In this study we evaluate an ultrasensitive prostate specific antigen assay in patients with prostate cancer after radical prostatectomy to predict long-term biochemical recurrence-free survival.
Do Ultrasensitive Prostate Specific Antigen Measurements Have a Role in Predicting Long-Term Biochemical Recurrence-Free Survival in Men after Radical Prostatectomy?
Journal of Urology | February 2016
Analytical Chemistry | February 2, 2016
The cell is the basic unit of biology and protein expression drives cellular function. Tracking protein expression in single cells enables the study of cellular pathways and behavior, but requires methodologies sensitive enough to detect low numbers of protein molecules with a wide dynamic range to…
Scientific Reports | June 8, 2015
Current technologies for cancer screening and detection typically rely on imaging techniques or blood tests that are not accurate or sensitive enough to definitively diagnose cancer at its earliest stages or predict biologic outcomes. By utilizing Single Molecule Arrays (SiMoA), an ultra-sensitive…
Fifth-Generation Digital Immunoassay for Prostate-Specific Antigen by Single Molecule Array Technology
Clinical Chemistry | October 13, 2011
Measurement of prostate-specific antigen (PSA) in prostate cancer patients following radical prostatectomy (RP) has been hindered by the limit of quantification of available assays. We developed an investigational digital immunoassay with a limit of quantification 2 logs lower than current…
Clinical Evaluation of a Novel Method for Measurement of PSA, AccuPSA™, as a Predictor of 5-year Biochemical Recurrence-free Survival Post Radical Prostatectomy: Results of a Pilot Study
BJU International | October 12, 2011
Nadir Ultrasensitive PSA levels has some value for predicting BCR following RD.